A new approach for treating colorectal cancer Scientists and surgeons in Princess Margaret Cancer Center can see a promising new approach to treating colorectal cancers by disarming the gene that drives self-renewal in stem cells that will be the real cause of disease, level of resistance to relapse and treatment. Colorectal cancer is the third leading reason behind cancer-related death under western culture. ‘This is the first step toward clinically applying the principles of cancers stem cell biology to control cancer growth and progress the development of long lasting cures,’ says principal investigator Dr.Demographic and clinical characteristics at baseline were balanced between the two study groups . General, 208 individuals , and 6.4 percent were lost to follow-up ; the average follow-up was 5.24 months. Over the two groups, check out completion prices ranged from 80 to 100 percent. For some visits, the rate was as low as 80 percent, whereas it was as high as 100 percent for other visits. Treatment adherence was around 78 percent in each treatment group. Blood Pressure, Hypertension Control, and Urinary Aldosterone Excretion The systolic blood pressures and mean arterial pressures, as assessed at home, were within the target range through the entire trial in 73 to 86 percent and 70 to 83 percent of the participants, but fewer participants had diastolic pressures in the mark range .23 mm Hg; 95 percent confidence interval [CI], 0.24 to 2.21; P=0.02) and mean arterial pressure , seeing that assessed at home .